FINANCIAL TIMES | Delivery dilemma for medical marijuana

For historical reasons, marijuana escaped the typical phases of a clinical study,” says Dr Gabriella Gobbi of the Faculty of Medicine at McGill University. “This is why we have medical cannabis but we don’t know its side effects.” Whether there is interaction with anti-depressants, she adds, “we don’t know.”

Read more